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Engaging veterinarians and farmers in 
eradicating bovine viral diarrhoea: a systematic 
review of economic impact
Matt J Yarnall, Michael V Thrusfield
Bovine viral diarrhoea (BVD) is a significant drain on efficient and successful cattle production in both dairy and 
beef systems around the world. Several countries have achieved eradication of this disease, but always through 
the motivation of stakeholders who accept the benefits of eradication. These include increased cattle welfare and 
fitness of cattle to withstand other diseases, and decreased costs of production, the latter resulting from both 
decreased costs spent on managing the disease and decreased losses. This paper provides a systematic review of 31 
papers, published between 1991 and 2015, that address the economic impact of BVD. Each paper takes a different 
approach, in either beef or dairy production or both. However with the breadth of work collated, a stakeholder 
engaged in BVD eradication should find an economic figure of most relevance to them. The reported economic 
impact ranges from £0 to £552 per cow per year (£2370 including outliers). This range represents endemic or 
subclinical disease situations seen in herds with stable BVD virus infection, and epidemic or severe acute situations, 
most often seen in naïve herds. The outcome of infection is therefore dependent on the immune status of the 
animal and severity of the strain. The variations in figures for the economic impact of BVD relate to these immune 
and pathogenicity factors, along with the variety of impacts monitored.
Introduction
Bovine viral diarrhoea
Bovine viral diarrhoea (BVD) is a disease caused by BVD virus 
(BVDV), a pestivirus belonging to the Flaviviridae family. The 
disease can manifest as generalised immunosuppression, with 
evidence of synergistic effects with other pathogens, fertility 
problems in male and female cattle, and other often more variable 
signs such as decreased milk production and weight gain, fever, 
diarrhoea and respiratory dysfunction.1–5 The extent of disease 
appears to be dependent on the level of immunity of the animal 
and pathogenicity of the virus strain.6 7
Control of BVD depends on removal of persistently infect-
ed (PI) animals, and maintenance of biosecurity to ensure that 
no new PI individuals are born. BVD is currently endemic in the 
majority of countries of the world, with control schemes pro-
gressing in Germany, Scotland, Belgium, Northern Ireland and 
Ireland, as well as regional schemes throughout many European 
countries.8–12 The basis for seeking freedom from BVDV in these 
countries has been economic, as well as on welfare grounds, and 
to promote proactive disease control rather than reactive disease 
control with associated increased use of antibiotics.13
Economic incentives for eradication programmes have been 
used both as a direct reward for culling of PI cattle and through 
the promise of greater efficiency and reduced losses.12 14 One 
incentive for many farmers involved in national BVD eradication 
schemes is the hope that they can stop vaccinating. While some 
countries have achieved eradication without vaccination, advanc-
es in cost-effective diagnostic testing mean that maintenance 
of biosecurity through vaccination when eradicating BVD is an 
option, as seen in Germany, Ireland and Scotland.
Veterinary practitioners are key to decisions regarding disease 
control on farms, certainly in the UK.15 However, it is apparent 
that veterinary practitioners need to have more of an understand-
ing of the economic impact of disease, not just welfare effects, 
because this often affects the willingness of a farmer to undertake 
an action.16 The economic assessments of national BVD control 
by Weldegebriel and others17 and Stott and others18 were integral 
to the implementation of the government-backed BVD eradica-
tion schemes in Scotland and Ireland, respectively. However, for 
voluntary schemes, such as those proposed for England and Wales, 
farmer and veterinary practitioner engagement will be essential 
to ensure the momentum to proceed to a compulsory phase (ref 19 
and N. Paton, personal communication).
Economic impact
Economic impact (cost, C) of BVD is determined by production 
losses (L) (direct and indirect) and control expenditures (E):
 C = L + E. 
With the aim of reducing L to 0, it may be beneficial to increase 
E in the short term on diagnostics, biosecurity and vaccination.20 
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So for the fixed period of an eradication scheme, it may appear 
the scheme is not cost beneficial; however, once freedom from the 
disease is achieved and maintained, it is cost-effective in the long 
term. The minimal, and therefore optimal, level of C may also be 
achieved over a defined period through use of an optimal level of 
E, which may not reduce L to 0.
Assessing the economic impact of BVD therefore needs an 
understanding and calculation of the losses and the expenditures 
of BVD being present in a herd, as well as an understanding of 
the objective of the assessment and whether it seeks to calculate 
an economic impact, avoidable loss or address a control choice 
or E. These figures can be assessed through looking at case his-
tories of losses from outbreaks, cost and benefits of farm-based 
or regional-based eradication schemes, or quantitative model-
ling. Quantitative modelling techniques for disease control take 
the form of four options: mathematical programming, network 
or decision analysis, simulation and cost–benefit analysis.20 21 
Mathematical programming is useful for structured decision prob-
lems, with various options to take into account and can involve 
linear or dynamic programming. Network analysis can contain 
qualitative and quantitative information, and is often a dia-
gram that can be used to describe, explain and analyse systems 
or processes. Decision analysis is similar to network analysis and 
is useful for poorly structured decision problems where risk and 
associated judgement is required. Cost–benefit analysis is an over-
all term for a number of ways of analysing different courses of 
action, but essentially it tries to identify, quantify and analyse 
the costs and benefits of a specific resource allocation decision 
using a partial budget structure often in a spreadsheet model. For 
national-level decisions, often the costs and benefits to society 
are considered, producing social cost–benefit analysis.21 22 This 
is often given as a net present value or as a ratio (cost:benefit or 
benefit:cost). Simulation allows experimentation with a model of 
a system rather than the system itself, and can incorporate the 
probability of events happening. Monte Carlo simulations use 
random numbers to simulate random processes, to take account 
of random distributions in the real world, resulting in a ‘see what 
happens’ analysis. Monte Carlo simulations are useful when mod-
els which are deterministic, or input-defined, and stochastic, or 
possess-inherent randomness, have no analytical solutions or are 
difficult to obtain. Markov processes or chains use transitional 
probabilities between the states of a system, for example, infected 
and immune. These processes can be mingled into one analysis.21
Methods and materials
A publication search was performed in PubMed and Web of 
Science to gather papers that are concerned with BVDV and 
associated economic impact, following the guidelines of the 
Preferred Reporting Items for Systematic Reviews and Meta-
Analyses.23 Additionally, Google Scholar also was used as a search 
resource. Language was limited to English. A search was made 
of the past 25 years (from 1991 to 2015) because this coincides 
with an increase in understanding of the disease and therefore an 
increase in publications on it.
Results that could not be accessed electronically or were 
repeats were removed. Papers were then submitted to one 
screening question: ‘Are numerical results produced that provide an 
assessment of the economic impact of BVD?’ Information used to pro-
vide the economic assessment was then assembled into a table 
(Microsoft Excel 2010; Microsoft, Redmond, USA).
An advanced search was made on PubMed (http://www. 
ncbi. nlm. nih. gov/ pubmed/ advanced) using the following search: 
((bovine viral diarrh*[Title] OR bovine virus diarrh*[Title] OR 
bvd[Title] OR bvdv[Title])) AND (economic*[Title] OR finan-
cial[Title] OR cost*[Title]).
The results were initially filtered on PubMed by selecting the 
article type and publication dates.
 ► article types: case reports, clinical trial, congresses, journal 
article, lectures, meta-analysis, observational study, review 
and systematic reviews
 ► publication dates: from January 1, 1991 to December 31, 2015.
The 24 results were filtered to remove any that were concerned 
either primarily with diagnostics or were not relevant, leaving 
20 results.
A second search was made in Google Scholar (https:// scholar. 
google. co. uk/), using the following searches: allintitle: bvd eco-
nomic OR economics OR financial OR cost OR costs, allintitle: 
bvdv economic OR economics OR financial OR cost OR costs, 
allintitle: bovine viral diarrhoea economic OR economics OR 
financial OR cost OR costs, allintitle: bovine viral diarrhea eco-
nomic OR economics OR financial OR cost OR costs, allintitle: 
bovine virus diarrhea economic OR economics OR financial OR 
cost OR costs, allintitle: bovine virus diarrhoea economic OR eco-
nomics OR financial OR cost OR costs.
The results were initially filtered on Google Scholar by select-
ing custom range and removing citations and patents.
Return articles dated between 1991 and 2015.
There were 53 articles returned, 16 repeats were removed, 5 
were removed that were involved in diagnostics and 2 that were 
not relevant, leaving 30 papers.
A final search was on Web of Science (V.5.21) (http:// 
apps. webofknowledge. com/ UA_ GeneralSearch_ input. 
do? product= UA& search_ mode= GeneralSearch& SID= 
W1Y13NkN8qgoWoHxoiI& preferencesSaved=) using the 
advanced search: TI=((bovine viral diarrh* OR bovine virus 
diarrh* OR bvd OR bvdv) AND (economic* OR financial OR 
cost*)).
Timespan: 1991–2015. Search language=auto
There were 41 results returned; 4 repeats were removed, 6 
diagnostic papers were removed and 2 papers that were not rele-
vant from the title were removed, leaving 29 papers.
All 79 articles were then reviewed and submitted to the 
screening question. Following analysis of the papers, seven further 
papers were then sourced. There were then 43 repeats, 2 editori-
al pieces, 1 model, 4 review articles and 1 comparing costs with 
and without vaccination that were removed. Four articles were 
not available, leaving 31 papers, which were copied to a Microsoft 
Word document (Microsoft Word 2010; Microsoft).
Papers included in the systematic review were from peer-re-
viewed journals unless otherwise stated.
Fig 1 shows the breakdown of the systematic search method.
Historical figures from these papers were converted to cur-
rent estimates, and this process can be illustrated by the equation 
below24:
Current value=Historical value × (1+inflation (%))number of years
However, this assumes a steady rate of inflation over many 
years. The Bank of England provides an online inflation calculator, 
which takes account of varying inflation rates over numbers of 
years, and this was used to produce the updated figures.25
Where results were given in a foreign currency, the figure was 
converted into pounds sterling before adjustment to present-day 
figures, using exchange rates at that time as provided by www. 
fxtop. com.26 Where economic impact figures were provided for 
the national herd in Great Britain, a figure per cow was calculat-
ed.27 28 The results were recorded to three significant figures.
Results
Table 1 displays the results of the systematic review of the 
economic impact of BVD from 1991 to 2015.
The majority of papers (19 out of 31) looked at the effects of 
BVD in dairy herds, with five papers looking at both dairy and 
beef cattle. There were seven papers that analysed a separate suck-
ler beef figure, and two papers considered beef fattening systems. 
Indirect losses, such as poorer milk quality and immunosuppres-
sive effects, are less well studied, compared with direct effects 
such as abortion.
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The range of economic impacts ranged from £0 to £2370, 
although this does include a severe BVD type 2 outbreak.29 
Removing this figure leaves a maximum figure of £552, which 
relates to the impact of reintroduction of BVD to a completely 
naïve herd after PIs have been removed.30 The mean economic 
impact of the 31 papers was £82.80. When adjusted by removing 
the severe type 2 outlier, this figure became £46.50.
Of the various searches performed, Google Scholar found 22 of 
the final 31 papers and 31 surplus papers. Web of Science found 22 
of the final 31 papers and 7 surplus papers, and PubMed found 17 
of the final 31 papers and 3 surplus papers. Google Scholar found 
the most results, but the search method is not simple to perform 
with multiple search terms, and inevitably it does return more 
repeated results. There were also more irrelevant results and more 
grey literature results.
Discussion
The variation seen in the outputs of the papers shows differences 
between the impact of endemic or subclinical BVD and epidemic 
or severe acute situations, which are usually associated with 
infection in a naïve herd. The impact of infection is therefore 
dependent on the immune status of the animal and severity of 
the strain. The range in economic impacts is also accounted for by 
differences in impact measurement.
Carman and others29 highlighted a range of impacts on dairy 
herds affected by the outbreak and discovery of BVDV type 2, and 
amounted to between £198 and £2370 in adjusted figures. There 
is little description of the calculation of this figure however. The 
Pasman and others30 paper addressing standard mixed endemic and 
epidemic infections in the Netherlands is interesting in that the 
authors assumed a lifelong immunity following infection. Scientific 
opinion more recently assumes only 12 months’ duration of immu-
nity because of the nature of BVDV and the fact that true immuni-
ty from BVD is not about protection for the vaccinated dam, but 
actually concerns sterile immunity, or freedom from challenge, for 
the fetus within.31 The Pasman and others30 paper was published a 
year or so before the widespread availability of efficacious vaccines 
in Europe, and the authors state that under no circumstances should 
PIs be removed from a herd, lest the herd becomes naïve and then 
suffer such a costly breakdown. Sørensen and others32 looked at the 
impact of BVD in a standard, naïve Danish dairy herd, and showed 
that while there appeared to be a significant difference in annual 
net revenue between a ‘no risk’ and ‘risk of introduction’ situation 
over the first five years of virus introduction, there was no signif-
icant difference in the following five years, hence the lowest eco-
nomic impact figure given as 0. Bennett and others33 also give a very 
low figure of between £2.25 and £13.50 (adjusted); however, it is 
worth noting that this assumes a national UK incidence of suscep-
tible herds of only 5 per cent, and only losses in those herds, not in 
herds that have endemic disease. The non-peer-reviewed paper by 
Bennett34 examines the effect of acute infection in fully susceptible 
dairy herds, and this provides a relatively high figure of up to £142. 
This may be because, as well as addressing widespread acute infec-
tion, he assumes that all infection occurs during gestation. In an all-
year-round calving herd this is unlikely; however, it does highlight 
the even higher economic risk to seasonal calving herds that suffer 
an outbreak in a naïve herd during the breeding season. Following 
the theme of immunity to BVDV, Chi and others35 assumed that 
40 per cent of vaccinated herds suffered no effects of BVD. From 
an immunological point of view, many BVD vaccines only provide 
a reduction in clinical effects of the disease, and failure to prevent 
the birth of PI animals is still a risk factor. Furthermore, from a com-
pliance point of view, it has been shown that the majority of vac-
cine is not used in a way that would provide the protection that is 
claimed.36 37 Bennett38 is a review of the Bennett and others33 paper, 
but with the impact of government subsidies removed, representing 
‘border prices’. Inflation-adjusted, both the maximum and mini-
mum values represent 37 per cent of the supported prices. Again, val-
ues are low as losses are assumed in only 5 per cent of UK herds that 
are naïve. Bennett also states that this variation in values reflects 
changes in the severity of the disease effects.
Houe24 is a review paper that collated a lot of the published infor-
mation; however, there were no formal selection criteria, and so it 
did not constitute a systematic review or meta-analysis. Stott and 
others39 looked at disease prevention measures to reduce avoidable 
losses and whether they were cost-effective, showing that costs and 
losses of BVD including biosecurity in susceptible herds were on 
average lower than the costs and losses of BVD in unknown-status 
herds that spent less on biosecurity. The lack of knowledge made 
BVD biosecurity a less attractive risk management strategy with 
the constraint of a fixed income, which ultimately did not pay off. 
Gunn and others40 is a non-peer-reviewed poster that showed that 
small herds with low milk price and high death rate experienced less 
expensive outbreaks, but proportionally lost 20 per cent of income 
over 10 years, whereas outbreaks in larger herds with higher milk 
price and lower death rate were more expensive in the short term 
but only suffered 8 per cent income loss over 10 years. Gunn and 
others41 is a paper relating to beef cattle using a Monte Carlo state 
transition model over 10 years, which highlighted that 53 per cent 
of expected losses are due to reduced reproductive efficiency, with 
the estimated overall impact on a beef suckler cow being between 
£45.30 and £56.10 with a mean of £51.30. This highlights the ongo-
ing impact of BVD in an endemic situation, due to the effect on 
seronegative animals within a herd. Fourichon and others42 looked 
in detail at the impact of BVD on dairy herds in France. The paper 
demonstrated two scenarios of an average case farm and a severe 
case farm, with the greatest impact being on milk yield, producing 
figures of between €75 and €133 (£69.20 and £123 updated), with-
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FIG 1: Recruitment and analysis of data through the different 
phases of the systematic review (from Moher and others23).
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TABLE 1: The results of the systematic review of the economic impact of BVD from 1991 to 2015
Paper Country
Dairy (D), beef 
(B) or beef 
fattening (F)
Endemic 
(End) or 
epidemic 
(Epi)
Standard (St) 
or severe 
(Se)
Method of 
economic 
assessment Costs
Source of costs 
and losses Losses
Figure produced per 
year per cow (year 
as per paper unless 
stated, and exchange 
rate if relevant)
Updated figure 
(£)
Bennett59 UK D End/Epi St Decision analysis Tx (TI), 
Tx (PI)
Literature A, ML (TI), ML (PI) 
Im, TI, Inf, Con, 
M (PI), M (TI) 
YGC (PI), YGC (TI)
£13.12–£98.96 24.50–185
Pasman and 
others30
Netherlands D End/Epi St Markov chain 
(MC) simulation 
model
D, Dis Literature, 
estimation, 
observation
M (TI), YGC (TI),
M (PI), ML (PI), 
ML (TI), Inf, A, 
YGC (PI), Con, PC
Year 1 cost – 49.55 
Dfl =
naive cost – 852.71 Dfl
2.77 NLG/£
=£17.9–£307
32.10–552
Sørensen and 
others32
Denmark D End/Epi St Stochastic 
simulation 
model
F, B Literature A, Inf, YGC (PI), 
Con, M (PI)
0–10,000 DKr (50 cow 
herd)=200 DKr
9.73 DKr/£ (1993)
£0–£20.6
0–37.80
Carman and 
others29
Canada D Epi Se Case study NA Farm data M (PI), M (TI), 
ML (PI), ML (TI), A
$C40,000 – £100,000 
per herd (40–191 
cows) = $209–$2500. 
$C1.94/£ (1993)
198–2370
Bennett and 
others33
Great Britain D/B End/Epi St Cost–benefit 
spreadsheet 
model
NA Research, VLA ML, A, M, PC £5.2–£31.0 m (3.9 m 
cows, 1996)
=£1.33–£7.95
2.25–13.50
Houe13 Denmark D End/Epi St/Se Cost–benefit 
spreadsheet 
model
NA Field cases, 
literature
R, TI, ML (TI), 
M (TI), A, Inf, Con, 
YGC (PI), M (PI)
US$20–US$57 per 
calving
$1.75/£ (1992)
21.30–60.90
Dufour and 
others60
France NA NA NA Simulation 
model
NA NA NA 25.5 F = €4.21
€1.75/£
3.76
Bennett34 UK D End/Epi St Decision analysis 
spreadsheet
NA Bennett59 M (PI), M (TI), 
Con, A, Inf, 
ML (TI), TI
£25.2–£90.7 (1999) 39.50–142
Chi and 
others35
Canada D End/Epi St Partial budget, 
risk and 
sensitivity 
analyses
Vet, Tx, L, 
Rep
Research ML (A), ML (TI), 
PC, M (PI), M (TI), 
A, YGC (PI), Inf
$C2422/50 cow herd
=48.44
$C2.36/£
30.10
Bennett38 Great Britain D/B End/Epi St Cost–benefit 
spreadsheet 
model
NA Bennett and 
others33
ML, A, M, PC £2–£12 m (3.7 m cows, 
1999)
=£0.54–£3.24
0.84–5.06
Houe24 Worldwide D End/Epi St/Se Review NA Review paper NA US$10–US$40 m/
million calvings
 US$1.63/£
8.74–35.0
Stott and 
others39
Scotland B End/Epi St Linear 
programming
BS, Rep, L Literature, 
SAC, vet 
interviews
Im, Con, YGC (TI), 
M (PI), A, Inf, PC
£20 status susceptible
£22 status unknown
28.50
31.40
Gunn and 
others40
UK D Epi St MC simulation 
model
NA Literature ML, M (PI) £10,300 (low median)
£10,400 (high 
median)
£20.6–£20.8/cow/
year
29.40–29.70
(29.50)
Gunn and 
others41
Scotland B End/Epi St MC simulation 
model
Vet, L, Dx, 
Tx, Rep
Literature, 
SAC, vet 
interviews
Im, Con, YGC (TI), 
A, M (PI), TI, 
Inf, PC
Transmission 
scenario low – 
£32.74, intermediate – 
£37.06, high – £40.53
45.30–56.10
(51.30)
Fourichon and 
others42
France D Epi/End St/Se Partial budget, 
no stochasticity
Rep, Tx, Literature, vet 
interviews
A, Inf, ML (A), 
M (PI), ML (TI), 
Mas, SCC, RP, M, TI
€75 (moderate) – 133 
(severe) €1.46/£
(no milk quota)
69.20–123
Gunn and 
others43
Europe D End St Stochastic 
simulation 
model
Vet, Tx, 
Rep
Expert opinion Inf, PC, Mas, E, 
R, ML
22% BVD-free 
annuity/farm
>£4200/65 cow = 
£64.60
87.00
Valle and 
others44
Norway D/B End St Stochastic 
simulation 
model
Vet, Tx Previous study 
on herd level 
effects
Inf, ML (TI), 
ML (PI), PC, M (TI), 
M (PI), TI
40–50 m Norwegian 
krone/year =
77 Norwegian krone 
per calving
10.5 Norwegian 
krone/£ (1993)
13.50
Bennett and  
IJpelar22
Great Britain D/B End St Cost–benefit 
spreadsheet 
model
D, Vac Bennett,38 
expert opinion
ML, Inf, PC, M, A £25.4–£61.1 m (3.2 m 
cows)
= £7.94–£19.1
10.70–25.70
Compton and 
others45
New Zealand D End St Case analysis NA Farm data A, Inf, ML NZ$90
NZ$2.83/£
41.50
Continued
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out considering effects of milk quota. Economic impact was less 
when milk yield was maintained with purchase of cows, and the 
highest cost was through increased mastitis. Gunn and others43 
proposed a figure for the maximum annual investment in BVDV 
prevention in dairy herds, justified to ensure that no PI is acquired. 
This was £64.60 per cow, or £87.00 after adjustment. This represents 
the benefit for a naïve herd excluding BVD from the farm. However, 
the authors concede that even this figure is conservative due to the 
difficulties in taking account of depressed fertility and immunosup-
pression in acutely infected animals.
Towards the end of Norway’s successful eradication of BVD, 
Valle and others44 produced a retrospective cost–benefit analysis 
after 10 years of BVD control. This stochastic simulation model 
used figures for the health, production and fertility impact of BVD 
from herds that were seropositive at the start of the eradication 
scheme. This is important to note because it should take account 
of the widest range of impacts of BVD, even in herds that have not 
isolated active infection, so can be seen as a ‘baseline impact’ of 
endemic disease, albeit in a low cattle density environment. The 
largest financial effects of BVD were seen in reproduction (extra 
days open) and extra animals lost, representing 24 per cent and 
Paper Country
Dairy (D), beef 
(B) or beef 
fattening (F)
Endemic 
(End) or 
epidemic 
(Epi)
Standard (St) 
or severe 
(Se)
Method of 
economic 
assessment Costs
Source of costs 
and losses Losses
Figure produced per 
year per cow (year 
as per paper unless 
stated, and exchange 
rate if relevant)
Updated figure 
(£)
Heuer and 
others46
New Zealand D End St Partial budget, 
retrospective 
case vs control
F Farm data Inf, A, (PR, 1st 
serve CR, CCI) PC, 
ML, M (PI)
NZ$87
NZ$2.72/£
40.00
Barbudo and 
others48
Scotland B End/Epi St MC and 
epidemiology 
model
B, F Literature, 
Gunn and 
others41
Inf, A £22–£43 26.50–51.80
Reichel and 
others47
New Zealand D End/Epi St/Se Decision analysis Separate 
costings
Voges and 
others61
M (PI), ML (PI), 
Mas (PI), YGC (PI)
NZ$11,344 (322 
cows/herd)=NZ$35.19
NZ$2.83/£ (2006)
16.20
Hessman and 
others3
USA F End St/Se Partial budget, 
retrospective 
case vs control
Tx (TI), Tx 
(PI), F
Farm data TI, R, Im, YGC (PI), 
YGC (TI), M (PI), M 
(TI), MD, PC
US$41.8–US$93.5
$1.56/£
32.40–72.50
Stott and 
others49
UK B End/Epi St/Se Simulation 
model
Rep, Vet, 
L (£1)
Literature, 
expert opinion
Im, Con, YGC (PI), 
YGC (TI), A, Inf, 
M (PI), PC
£0–£40
(2008)
48.10
Häsler and 
others50
Switzerland D/B End St Partial budget 
spreadsheet 
model
Vet, 
Tx (TI), 
Tx (PI), D, 
Dis, L
Literature, 
expert opinion
M (PI), M (TI), 
PC, A, ML (PI), 
ML (TI), TI
16.04 m CHF (1.5 m 
cows)
=10.7 CHF
1.99CHF/£ (2008)
6.46
Stott and 
others18
Ireland D End/Epi St Simulation 
model
Vet, 
Tx (PI), Tx 
(TI), Rep
Weldegebriel 
and others17
ML (TI), ML (A) 
PC, Im, Mas, Inf, 
E, R, TI
€63
€1.23/£ = £51.2
54.50
B Simulation 
model
Vet, Rep 
Tx (TI), 
Tx (PI), L,
Stott and 
others,49 SAC, 
vet interviews
Im, PC, Con, 
YGC (PI) YGC (TI), 
A, Inf, M (PI)
€32 (€29 small – €38 
large)
€1.23/£ = £21.1
20.40–26.70
22.50
F Partial budget 
MC spreadsheet
Vet, 
Tx (TI), L, 
Tx (PI)
Expert panel, 
Gunn and 
others41
YGC (TI), YGC (PI) €19
€1.23/£ = £15.4
16.40
Smith and 
others51
USA B End St Stochastic model NA Literature, 
surveys, 
expert opinion
A, M (TI), M (PI), 
TI, YGC (TI), 
YGC (PI), Inf, Con
US$205,429 (460 
cows/10 years) = 
$44.66
US$1.65/£ = £27.0
27.30
Knific and 
Zgajnar52
SIovenia D End St MC simulation Rep, F, Vet, 
Tx,
Jeric (2011) ML (TI), ML (PI), 
PC, YGC (TI), 
YGC (PI), A, 
M (TI), M (PI), Inf, 
Mas, RP
€189
€1.24/£
= £152.4
154
Szabára and 
Ózsvári53
Hungary D End St Partial budget 
estimations
NA Own 
calculations
ML (TI), A, M (TI), 
M (PI), PC,
€13.7
€1.24/£
= £11.0
11.10
Santman-
Berends and 
others54
Netherlands D End St Stochastic 
simulation 
model
Vac, D, 
Rep, Vet
Hogeveen55 A, Con, YGC (PI), 
YGC (TI), ML, TI, 
PC, M (TI), M (PI), 
Inf
€30.8 m/year (1.6 m 
dairy cows) = $19.25 
(2014)
1.24€/£ = £15.5
15.70
Karabozhilova 
and others19
England D/B End St Partial budget 
analysis
Tx (TI), 
Tx (PI), 
Dis, Rep, 
Vet, D, F, B
Literature, 
case reports, 
Häsler and 
others50
M (PI), M (TI), PC, 
ML (PI), ML (TI), 
TI, Inf, A
Dairy – £21.32 and 
£42.63; beef – £26.78 
and £53.56
31.50
40.20
Premature cull costs may include replacement costs minus slaughter value. TI losses may also be represented by treatment costs. 
A, abortion; B, decreased bedding costs; BS, biosecurity costs; BVD, bovine viral diarrhoea; Cd, newborn calf death; Con, congenital defects; D, diagnostics; Dis, disposal costs; E, enteritis; 
F, decreased feed costs; Im, immunosuppression; Inf, infertility (days open, returns to service); L, increased labour costs; M (PI) (MD included), mortality of PIs; M (TI), mortality of acutely 
infected animals; Mas, mastitis; ML (A), milk loss following abortion; ML (PI), milk loss from PI cow; ML (TI), milk loss from acute infection; NA, (data) not available or applicable; PC, 
premature culling; R, respiratory disease; Rep, replacement costs; RP, retained placenta; SAC, Scottish Agricultural College; SCC, decreased milk quality; TI, acute infection; Tx (PI), PI 
treatment costs; Tx (TI), acute infection treatment costs; V, vaccination; Vet, veterinary cost; YGC (PI), youngstock growth check of PIs; YGC (TI), youngstock growth check of acute infected 
animals; 
TABLE 1: Continued 
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28 per cent of the total financial loss, respectively. Prenatal infec-
tions represented 37 per cent of losses.
In the most recent update to the Reading model, Bennett 
and IJpelaar22 examined the welfare impact of endemic diseases 
including BVD. Although there is no economic value produced 
for the welfare impact, the increased BVD impact figure, when 
compared with the authors’ previous estimates of £10.70–£25.70, 
represents revised and updated estimates of key disease variables, 
as well as revised numbers of animals affected, with a mean of 
10 per cent of breeding cows. Work from New Zealand45 46 looked 
at a similar data set of around 600 dairy herds, and analysed bulk 
tank milk BVDV antibodies and associations with production 
and health parameters. The Compton and others paper45 was a 
proceedings paper; however, the later peer-reviewed Heuer and 
others paper46 showed that there was a 2 per cent increase in 
abortion rates, an increase from calving to conception of 2.4 days, 
and 5.8 per cent decrease in total milk production with increasing 
bulk milk antibody level. This thorough data analysis produced 
partial budget losses of NZ€87 per cow, giving an adjusted fig-
ure of £40.00. However, the authors concede the figure to be con-
servative because there was no consideration of impact on calf 
health, mastitis or retained placentae. A later paper by Reichel and 
others47 produced a lower figure of £16.20; however, within this 
decision-tree analysis, there is no consideration of the effects of 
transient infection or immunosuppression. As mentioned above 
with regard to assumed vaccine efficacy, this paper used a figure 
of a maximum of 80 per cent when analysing cost-effectiveness of 
control options.
Barbudo and others48 calculated that reproductive failure 
could account for up to 23 per cent loss in gross margin for beef 
suckler herds suffering BVD effects over a 10-year period follow-
ing an initial epidemic. These costs, however, were often hidden 
by an extended breeding season. Hessman and others3 looked at 
the impact of BVD in a feedlot situation by analysing data ret-
rospectively from over 20,000 calves using a partial budget anal-
ysis. The varying levels of exposure to PIs showed performance 
losses of acutely infected animals amounted to between £32.40 
and £72.50 (adjusted figures), corresponding to $41.84 and $93.52 
from the original analysis. There was also a 55 per cent increase 
in feed conversion efficiency for those cattle not exposed to PIs 
(P=0.03), which, along with differences in fatalities, would have 
accounted for the greatest economic impact. This difference was 
only in the 66 days of the feeding period that was analysed, and 
the mean bodyweight of youngstock was 233.182 kg ± 1.7 kg 
(standard error of the mean) on arrival.
Stott and others49 again looked at beef herds, producing a fig-
ure of up to £48.10 (adjusted). The paper highlighted the risk of 
reintroduction of disease and showed that the higher the proba-
bility of further infection, the greater the cost of disease. Of note 
in this paper is that veterinary and labour costs were included; 
however, labour costs were put at an arbitrary level of £1 an hour, 
representing the low opportunity cost of family labour often used 
in those farms studied.
Häsler and others50 analysed the cost–benefit of the Swiss 
eradication scheme using a spreadsheet model, producing a fig-
ure of just over SFr16 million for the impact on the whole cattle 
population. Mortality and milk yield were the most significant 
contributors to losses. The adjusted figure of £6.46 seems low; 
however, as this was based on 2008 figures, the figure is affected 
by the strength of sterling compared with the present day, and 
may also represent differences in cattle production. In 2012, Stott 
and others produced economic impact figures to support the Irish 
BVD eradication scheme. In the paper they analysed dairy, beef 
suckler and beef finisher systems in stochastic, Markov chain, par-
tial budget simulations. The impact in dairy herds was greater, at 
$63 per cow (£54.30 adjusted figure) compared with beef suck-
ler herds at an average of $32 per cow (£27.70 adjusted). Smaller 
herds (<51 cows) were affected more per cow than larger herds 
at $38 compared with $29. Beef finisher units suffered an impact 
of $19 (£16.40 adjusted) per cow per year, mainly through loss of 
value and growth rate and increased treatment costs.
Smith and others51 looked at cost-effectiveness of BVD control 
measures, and produced a figure for the impact of BVD in beef 
suckler herds of £27.30 (adjusted). The figure was produced by 
bringing three Monte Carlo simulation models together, which 
each looked at annual risk of BVDV introduction, effects of BVDV 
over 10 years after introduction to a naïve herd and a model for 
the economic costs of BVDV infection. A non-peer-reviewed 
poster52 was produced on the impact of BVD on Slovenian dairy 
herds, based on a Monte Carlo simulation model. The main costs 
identified were lower milk yield and additional treatment costs, 
with a final adjusted figure of £155. There was an assumption 
in the simulation however of a PI animal incidence of 2 per cent, 
with 40 per cent naïve animals and 58 per cent acutely infected. 
There was also a paper53 that used the authors’ own calculations 
to produce a figure for the impact of BVD in the Hungarian dairy 
sector of £11.20 (adjusted); however, there was no effect of infer-
tility, immunosuppression or other subclinical effects. Santman-
Berends and others54 recently produced a stochastic model for the 
eradication of BVD from the Netherlands’ dairy industry. It was 
assumed that a herd would go from immune to susceptible when 
50 per cent of the herd were seronegative through replacement 
only, not through waning of immunity. Furthermore, for vaccinat-
ed herds they assumed no losses due to BVD, and only 0.1 per cent 
probability of ineffective vaccination and 10 per cent of herds 
not vaccinating effectively. This was using the six-monthly BVD 
vaccine, Bovilis BVD (MSD). The paper based the impact figures 
on Hogeveen and others,55 which is in Dutch. Santman-Berends 
and others54 produced an average figure of €72 per milking cow, 
altered for inflation. Production losses in youngstock were not 
considered. The economic impact produced was £15.70, after 
adjustment.
The final paper19 that has been included is work from the 
Royal Veterinary College, London, which was commissioned by 
the AHDB Dairy (DairyCo) for the English BVD working group, 
and is at the time of writing unpublished. The partial budget 
analysis addressed costs and losses associated with BVD in beef 
and dairy herds, and calculated that BVD costs the dairy industry 
between £21.32 and £42.63 per cow, with the impact split with 
37 per cent losses and 63 per cent costs. The impact split in the 
beef sector was 50/50, with a resulting range of £26.78 and £53.55.
Some papers of relevance were not included in this review 
because they were published before the set timeline, in a foreign 
language or were part of other papers. Wentink and Dijkhuizen56 
looked at a case study of 14 Dutch dairy farms affected by BVD, 
and provided a figure of around 136 Dfl (£86) per dairy cow with 
herd variation of 42–285 Dfl (£26.60–£180). Bennett and others57 
produced similar data to a paper already included.33 Also of inter-
est is a recent paper by Gates and others58 looking at the impact 
of BVDV seropositivity on performance indicators in 255 Scottish 
beef suckler herds and 189 Scottish dairy herds. On average, calf 
mortality rates were 1.35 per cent higher in seropositive beef herds 
and 3.05 per cent higher in dairy herds. While no economic fig-
ure was provided, this paper is of relevance because farmers will 
appreciate the economic impact of this on farm.
In summary, the economic impact of BVD ranges from £0 to 
£552 per cow per year, with a mean impact of £46.50. Endemically 
infected herds would be experiencing an impact of between 
£6.46 and £87 per cow per year, with outbreaks in naïve herds 
ranging from £28.50 to £2370 with a severe outbreak of virulent 
virus. There appears to be no consistent differentiation between 
the level of impact in beef and dairy systems; however, the impact 
of BVD infecting a large proportion of calves in a tight calving beef 
system cannot be overestimated. Most losses occur through repro-
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ductive issues and most analyses, whether on-farm or otherwise, 
will underestimate impact of secondary issues such as immuno-
suppression. Potential losses can be reduced through use of effec-
tive vaccination; however, ultimately eradication of BVD needs 
to be viewed as an investment, with costs of diagnostic testing, 
PI removal, vaccination and monitoring being factored against 
reduced losses in the long term.
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